PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.\', \'Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA. leafh@email.unc.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s12943-021-01335-5
?:hasPublicationType
?:journal
  • Molecular cancer
is ?:pmid of
?:pmid
?:pmid
  • 33632261
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.778
?:rankingScore_hIndex
  • 96
is ?:relation_isRelatedTo_publication of
?:title
  • mRNA vaccine for cancer immunotherapy.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33632261>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33632261>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all